Use of Continuous Glucose Monitoring System With Intensive Feedback in Adolescents With Poorly Controlled Type 1 Diabetes



Status:Enrolling by invitation
Conditions:Diabetes, Diabetes
Therapuetic Areas:Endocrinology
Healthy:No
Age Range:13 - 19
Updated:12/14/2018
Start Date:November 2015
End Date:November 2020

Use our guide to learn which trials are right for you!

Trial Summary
Trial Overview
Inclusion Criteria
The purpose of this study is to determine that continuous glucose monitoring systems (CGMS)
with intensive real time feedback about diabetes management from medical staff to the patient
will affect motivation and/or behavior, in adolescents with poorly controlled type 1
diabetes. Investigators hypothesize that short-term CGMS use with feedback (and/or lack
thereof) and patients' sense of self-efficacy

Sixty adolescents, ages 13-19 years, with type 1 diabetes and an HbA1c > = 8 % who are also
naive to CGMS use will be recruited from the diabetes outpatient population followed at
Bellevue Hospital, Lutheran Hospital, Woodhull Hospital, and the NYU Fink Pediatric
Ambulatory Care Center. Forty subjects will be randomly assigned to the CGMS group and 20
subjects will be assigned to the control group.

Inclusion Criteria:

- type 1 diabetes

- HbA1c > = 8 %

- naive to CGMS use

Exclusion Criteria:

- Patients with developmental delay

- Patients who do not use a glucose meter to test capillary blood glucose level

- Patients without access to a telephone will be excluded.
We found this trial at
1
site
New York Univ. Medical Center
New York, New York 10021
?
mi
from
New York, NY
Click here to add this to my saved trials